Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse.
de Haas
V
V
Breunis
W B
WB
Verhagen
O J
OJ
van der Berg
H
H
van der Schoot
C E
CE
D002051:Burkitt Lymphoma / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D012008:Recurrence